Log In
Print
BCIQ
Print
Print this Print this
 

FX005

  Manage Alerts
Collapse Summary General Information
Company Flexion Therapeutics Inc.
DescriptionInhibitor of p38 mitogen-activated protein kinase (p38 MAPK; MAPK14)
Molecular Target p38 mitogen-activated protein kinase (p38 MAPK) (MAPK14)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today